SPECIALTY TOPICS · GUIDE
Prescription Requirements for Peptide Medicines
Which peptide medicines are prescription-only, what a prescription does and does not mean for compounded or unapproved products, and what US and UK regulators say, with sources.
Content last updated . This page has not been medically reviewed.
Back to Peptides & Modern ResearchWhy a prescription matters
A prescription means a licensed professional assessed the person and chose the product. It does not mean the product is approved, tested or free of risk. These are separate questions, as the table shows.| Situation | What a prescription does and does not mean |
|---|---|
| Approved medicine, supplied by a licensed pharmacy | Labeled, reviewed product. For example, the US label for Wegovy (semaglutide) reads "Rx only." [1] |
| Compounded product | A prescription is one condition of US compounding; it does not make the product FDA-approved. [2] |
| Product sold online as "research" | No prescription step, and not an approved route. See Research Use Only Labels |
United States
- Approved product example. The DailyMed label for Wegovy (semaglutide), effective 2026-06-18, is marked "Rx only." [1]
- FDA advice on GLP-1 drugs. FDA says patients should obtain a prescription from their doctor and fill it at a state-licensed pharmacy. [3]
- Compounding is not approval. FDA states that compounded drugs are not FDA-approved and that it does not review them for safety, effectiveness or quality before they are marketed. [3] Under section 503A, one condition for the exemptions is that drugs be compounded on receipt of valid patient-specific prescriptions. [2]
- Ingredient limits apply. A 503A compounder may use bulk drug substances only if they meet a USP or NF monograph, are components of an FDA-approved product, or appear on FDA's 503A bulks list. [4] So a prescription cannot by itself make any ingredient lawful to compound. For BPC-157, FDA's July 2026 advisory committee briefing says there is no approved product containing BPC-157-related bulk drug substances in any country. [5]
- Why self-treatment is the issue. In one warning letter FDA wrote that the prescription drugs involved were intended for conditions not amenable to self-diagnosis and treatment by a layperson. [6]
United Kingdom
The MHRA said on 29 December 2025 that some weight-management medicines, including all GLP-1 medicines, are prescription-only and should only be supplied after a proper assessment by a qualified healthcare professional. [7] In December 2024 it described them as powerful medicines that can only be legally and safely dispensed against a prescription from a healthcare professional. [8] These statements concern GLP-1 weight-management medicines. They do not describe every peptide.Other countries
Proper evidence not found. The Australian (TGA) and Canadian (Health Canada) pages I tried would not load this session, and I did not look at the EU/EMA for this page. Do not assume a status from another country; check the regulator's own page or ask a pharmacist.Frequently asked questions
Are all peptide medicines prescription-only?
No. Status depends on the country and the specific product. This page verified prescription status only for Wegovy (US label) and for GLP-1 weight-management medicines (UK, MHRA). [1][7]
Does a prescription make a compounded peptide FDA-approved?
No. FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before marketing. [3]
Can a doctor prescribe any peptide to be compounded in the US?
Not freely. Under section 503A, bulk ingredients must meet a monograph, be a component of an approved product, or be on FDA's 503A bulks list. [4]
Is BPC-157 an approved prescription medicine?
FDA's July 2026 briefing says there is no approved product containing BPC-157-related bulk drug substances in any country at this time. [5]
What if a website sells a peptide with no prescription?
In the US, FDA says people should get a prescription and use a state-licensed pharmacy. [3] The UK MHRA says to buy only from registered UK pharmacies or legitimate retailers. [7]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Practical cautions
- A clinic offering a peptide does not make it approved. See Approved, Investigational and Unapproved Peptides.
- For compounding questions see Compounded Medicines and Compounded vs Approved Products.
- For weight-medicine specifics see Compounded and Unapproved GLP-1 Products.
- Talk with your prescriber or pharmacist about your own medicines. Do not stop a prescribed medicine because of this page.
References
- U.S. prescribing information for WEGOVY (semaglutide), DailyMed (label version effective 2026-06-18). Read 2026-10-22.
- FDA, Compounding Laws and Policies (page marked current as of 12/17/2024). United States. Read 2026-10-22.
- FDA, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (page marked current as of 10/01/2026). United States. Read 2026-10-22.
- FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act (page marked current as of 05/14/2026). United States. Read 2026-10-22.
- FDA, Briefing Document, Pharmacy Compounding Advisory Committee, July 23-24, 2026: BPC-157-related bulk drug substances. United States. Read 2026-10-22.
- FDA CDER, Warning letter to an online seller, February 2025. United States. Read 2026-10-22.
- MHRA, MHRA urges public to avoid illegal online weight-loss medicines this New Year, December 29, 2025. United Kingdom. Read 2026-10-22.
- MHRA, UK medicines regulator warns against buying weight loss medicines without a prescription this New Year, December 30, 2024. United Kingdom. Read 2026-10-22.